BioScrip to Host Third Quarter Results Call
October 16 2017 - 8:00AM
BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced that the Company will release
its third quarter 2017 financial results on Thursday, November 2,
2017 before the opening of U.S. financial markets.
Daniel E. Greenleaf, President and Chief Executive Officer, and
Stephen Deitsch, Senior Vice President, Chief Financial Officer and
Treasurer, will conduct a conference call as follows:
Date |
|
November 2, 2017 |
Time |
|
9:00 a.m. EDT |
Toll free (U.S.) |
|
(888) 372-9592 |
Webcast (live and
replay) |
|
www.bioscrip.com |
|
|
|
A replay of the conference call will be available two hours
after the call's completion by dialing (855) 859-2056 (US) and
entering conference call ID number 1115410.
About BioScrip
BioScrip, Inc. is the largest independent
national provider of infusion and home care management solutions,
with approximately 2,200 teammates and nearly 80 service locations
across the U.S. BioScrip partners with physicians, hospital
systems, payors, pharmaceutical manufacturers and skilled nursing
facilities to provide patients access to post-acute care services.
BioScrip operates with a commitment to bring customer-focused
pharmacy and related healthcare infusion therapy services into the
home or alternate-site setting. By collaborating with the full
spectrum of healthcare professionals and the patient, BioScrip
provides cost-effective care that is driven by clinical excellence,
customer service, and values that promote positive outcomes and an
enhanced quality of life for those it serves.
Investor
Contacts |
|
|
|
|
|
Stephen
Deitsch |
|
David Clair |
Chief Financial Officer
& Treasurer |
|
ICR, Inc. |
T: (720) 697-5200 |
|
T: (646) 277-1266 |
stephen.deitsch@bioscrip.com |
|
david.clair@icrinc.com |
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Apr 2023 to Apr 2024